• Pharmaceutical company in its defense of putative class actions filed by direct and indirect purchasers and an action brought by the Federal Trade Commission based on an alleged “reverse payment” patent litigation settlement.
    • Generic pharmaceutical company in its defense of antitrust price-fixing litigation brought by government entities and putative classes of direct purchasers, end-payors, and indirect reseller plaintiffs.
    • Insurer in its defense of an antitrust action brought by a putative class of ophthalmologists.
    • Milk supplier in defense of antitrust claims brought by retail plaintiffs.
    • Front of the Class: Cutting-Edge Strategies for Defeating Class Certification- Dechert LLP and Lexology, Webinar (November 17, 2020)